Dania Movia, Despina Bazou & Adriele Prina-Mello
BMC Cancer volume 19, Article number: 854 (2019) Cite this article
Lung cancer is the leading cause of cancer-related deaths worldwide. This study focuses on its most common form, Non-Small-Cell Lung Cancer (NSCLC). No cure exists for advanced NSCLC, and patient prognosis is extremely poor. Efforts are currently being made to develop effective inhaled NSCLC therapies. However, at present, reliable preclinical models to support the development of inhaled anti-cancer drugs do not exist. This is due to the oversimplified nature of currently available in vitro models, and the significant interspecies differences between animals and humans.
Article available here: https://bmccancer.biomedcentral.com/arti...2885-019-6038-x